Clinical Significance of CD 34 Expression in Childhood Acute Lymphoblastic Leukemia

[1]  J. Testa,et al.  The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia. , 1992, Leukemia.

[2]  R. Notaro,et al.  PROGNOSTIC IRRELEVANCE OF CD34 IN ACUTE MYELOID LEUKAEMIA , 1992, British journal of haematology.

[3]  J. Krischer,et al.  Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  N. Lucie,et al.  The prognostic significance of the CD34 antigen in acute myeloid leukaemia. , 1992, Leukemia & lymphoma.

[5]  I. Bernstein,et al.  Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance. , 1992, Blood.

[6]  D. Tenen,et al.  Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. , 1992, Journal of immunology.

[7]  F. Behm,et al.  Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. , 1991, The New England journal of medicine.

[8]  T. Rabbitts.  Translocations, master genes, and differences between the origins of acute and chronic leukemias , 1991, Cell.

[9]  M. Sanz,et al.  PROGNOSTIC VALUE OF CD34 EXPRESSION IN DE NOVO ACUTE MYELOBLASTIC LEUKAEMIA , 1991, British journal of haematology.

[10]  M. Relling,et al.  Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia. , 1991, Seminars in hematology.

[11]  H. Sather,et al.  Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  F. Behm,et al.  Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy , 1991, The Lancet.

[13]  S. Piantadosi,et al.  Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10) , 1990, British journal of haematology.

[14]  C. Pui,et al.  Biology and Clinical Significance of Cytogenetic Abnormalities in Childhood Acute Lymphoblastic Leukemia , 1990 .

[15]  A. Look,et al.  Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Shuster,et al.  Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Treille,et al.  Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy , 1989, British journal of haematology.

[18]  I. Bernstein,et al.  Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties , 1989, The Journal of experimental medicine.

[19]  S. Bigner,et al.  Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. , 1989, American journal of clinical pathology.

[20]  M. Borowitz,et al.  Asynchronous Antigen Expression in B Lineage Acute Lymphoblastic Leukemia , 1988 .

[21]  M R Loken,et al.  Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. , 1987, Blood.

[22]  R. Hoffman,et al.  Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies. , 1987, Journal of immunology.

[23]  C. Pui,et al.  High risk lymphoblastic leukemia in children: prognostic factors and management. , 1987, Blood reviews.

[24]  C. Pui,et al.  Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. , 1985, Blood.

[25]  D. Williams,et al.  A direct bone marrow chromosome technique for acute lymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.

[26]  H. Gralnick,et al.  The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical Correlations , 1981, British journal of haematology.

[27]  Xingyue He,et al.  Isolation and Molecular Characterization of the Human CD 34 Gene , 2003 .

[28]  C. Civin,et al.  Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells. , 1992, Leukemia.